The ability of steroid hormones to influence profoundly the excitability of the CNS is well documented. The broad objective of this proposal is to explore pharmacologically the molecular mechanisms whereby steroids modulate CNS excitability. Abnormal activation of amino acid receptors has been proposed to play a role in the etiology of psychiatric disorders such as anxiety, depression and schizophrenia. Understanding the mechanisms of steroid actions on the CNS may lead to new strategies for the treatment of psychiatric disorders. During the course of our studies we came upon the unexpected finding that pregnenolone sulfate (PS), an abundant neurosteroid, acts as a positive allosteric modulator at the NMDA receptor while inhibiting the kainate, AMPA, glycine, and GABA responses. A major focus of the research plan will be to test our working hypothesis that steroids such as PS regulate the balance between excitation and inhibition on neurons derived from the vertebrate CNS by acting on excitatory and inhibitory amino acid receptors. Toward this end, whole-cell voltage-clamp and current-clamp techniques will be utilized to character electrophysiologically the effects of PS and related steroids on excitatory and inhibitory amino acid receptor-mediated responses of embryonic chick spinal cord neurons maintained in primary monolayer cell culture. The proposed study has three major parts: First, we will screen a series of steroids for activity on amino acid receptor-mediated currents. Secondly, we will determine the potency, efficacy, and mode of action for PS and each steroid identified, with the goal of elucidating the mechanism(s) of steroid action(s) through a study of their structure-activity relationships. In particular, we will focus our studies on PS and on other steroids that are active at NMDA and non-NMDA glutamate receptors. Finally, the effects of steroids on excitatory and inhibitory synaptic transmission at single synapses will be investigated. In the long run, we will determine whether chronic treatment with active steroids such as PS, progesterone, and reduced metabolites of progesterone induces functional changes of excitatory or inhibitory amino acid receptors and of synaptic transmission at identified synapses. These studies will provide a strong basis for evaluating the role of steroids as modulators of neuronal function, and a foundation for development of novel steroid-based drugs for the treatment of psychiatric disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH049469-03
Application #
2248887
Study Section
Neurosciences Research Review Committee (BPN)
Project Start
1992-06-01
Project End
1997-05-31
Budget Start
1994-06-01
Budget End
1995-05-31
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Boston University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Smith, Conor C; Martin, Stella C; Sugunan, Kavitha et al. (2014) A role for picomolar concentrations of pregnenolone sulfate in synaptic activity-dependent Ca2+ signaling and CREB activation. Mol Pharmacol 86:390-8
Smith, Conor C; Gibbs, Terrell T; Farb, David H (2014) Pregnenolone sulfate as a modulator of synaptic plasticity. Psychopharmacology (Berl) 231:3537-56
Kostakis, Emmanuel; Smith, Conor; Jang, Ming-Kuei et al. (2013) The neuroactive steroid pregnenolone sulfate stimulates trafficking of functional N-methyl D-aspartate receptors to the cell surface via a noncanonical, G protein, and Ca2+-dependent mechanism. Mol Pharmacol 84:261-74
Kostakis, Emmanuel; Jang, Ming-Kuei; Russek, Shelley J et al. (2011) A steroid modulatory domain in NR2A collaborates with NR1 exon-5 to control NMDAR modulation by pregnenolone sulfate and protons. J Neurochem 119:486-96
Eagleson, K L; Gravielle, M C; Schlueter McFadyen-Ketchum, L J et al. (2010) Genetic disruption of the autism spectrum disorder risk gene PLAUR induces GABAA receptor subunit changes. Neuroscience 168:797-810
Berezhnoy, D; Gibbs, T T; Farb, D H (2009) Docking of 1,4-benzodiazepines in the alpha1/gamma2 GABA(A) receptor modulator site. Mol Pharmacol 76:440-50
Berezhnoy, Dmytro; Gravielle, Maria C; Downing, Scott et al. (2008) Pharmacological Properties of DOV 315,090, an ocinaplon metabolite. BMC Pharmacol 8:11
Sadri-Vakili, G; Janis, G C; Pierce, R C et al. (2008) Nanomolar concentrations of pregnenolone sulfate enhance striatal dopamine overflow in vivo. J Pharmacol Exp Ther 327:840-5
Whittaker, Matthew T; Gibbs, Terrell T; Farb, David H (2008) Pregnenolone sulfate induces NMDA receptor dependent release of dopamine from synaptic terminals in the striatum. J Neurochem 107:510-21
Jang, Ming-Kuei; Mierke, Dale F; Russek, Shelley J et al. (2004) A steroid modulatory domain on NR2B controls N-methyl-D-aspartate receptor proton sensitivity. Proc Natl Acad Sci U S A 101:8198-203

Showing the most recent 10 out of 19 publications